Home › Sprint Bioscience Enters into Collaboration with Bayer Healthcare on Tumor Metabolism Program
 

Keywords :   


Sprint Bioscience Enters into Collaboration with Bayer Healthcare on Tumor Metabolism Program

2015-07-28 09:16:55| Appliances - Topix.net

Sprint Bioscience AB and Bayer HealthCare have entered into a collaboration and license agreement for the research, development, and commercialization of oncological drug candidates. Under the agreement, Sprint Bioscience licenses an early-stage inhibitor program targeting tumor metabolism to Bayer.

Tags: program collaboration healthcare metabolism

Category:Consumer Goods and Services

Latest from this category

All news
18.05M&S website and app hit by technical issue
18.05Unpaid carers being forced to repay 250m to DWP
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
17.05Boeing boss's $33m pay package approved
17.05Urban Decay Renews Sponsorship Agreement with the Los Angeles Sparks
Consumer Goods and Services »
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »